These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Relationship of large and small CD3- CD56+ lymphocytes mediating NK-associated activities. Ortaldo JR; Winkler-Pickett R; Kopp W; Kawasaki A; Nagashima K; Okumura K; Yagita H; Bach FH J Leukoc Biol; 1992 Sep; 52(3):287-95. PubMed ID: 1381742 [TBL] [Abstract][Full Text] [Related]
46. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion. Jewett A; Bonavida B Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529 [TBL] [Abstract][Full Text] [Related]
47. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor. Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601 [TBL] [Abstract][Full Text] [Related]
48. Distribution of Leu-19(CD56) natural killer lymphocyte antigen in cultured cells from the human embryonic central nervous system. Aloisi F; Samoggia P; Montesoro E; Testa U; Levi G; Peschle C Ann N Y Acad Sci; 1992 Apr; 650():317-21. PubMed ID: 1376574 [No Abstract] [Full Text] [Related]
49. LDL and acetyl-LDL inhibit the NK activity and are taken up by CD56+ lymphocytes. Juompan L; Fournié GJ; Benoist H Biochim Biophys Acta; 1994 Oct; 1224(1):1-10. PubMed ID: 7524682 [TBL] [Abstract][Full Text] [Related]
50. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Morrison LJ; Behan WH; Behan PO Clin Exp Immunol; 1991 Mar; 83(3):441-6. PubMed ID: 1706238 [TBL] [Abstract][Full Text] [Related]
51. Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding. Voss SD; Robb RJ; Weil-Hillman G; Hank JA; Sugamura K; Tsudo M; Sondel PM J Exp Med; 1990 Oct; 172(4):1101-14. PubMed ID: 1698909 [TBL] [Abstract][Full Text] [Related]
52. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. Saxon A; Ke Z; Bahati L; Stevens RH J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):333-44. PubMed ID: 1698844 [TBL] [Abstract][Full Text] [Related]
53. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro. Higuchi CM; Thompson JA; Lindgren CG; Gillis S; Widmer MB; Kern DE; Fefer A Cancer Res; 1989 Dec; 49(23):6487-92. PubMed ID: 2479463 [TBL] [Abstract][Full Text] [Related]
54. Leu-19 in myeloma--a new role for an old antibody. Wetter O; Brandhorst D; Reiter W Eur J Cancer; 1990 Apr; 26(4):541. PubMed ID: 1694090 [No Abstract] [Full Text] [Related]
55. Natural killer cell subsets and alloresponsiveness in renal allograft recipients. Shabtai M; Waltzer WC; Pullis CK; Raisbeck AP; Malinowski K; Rapaport FT Transplant Proc; 1990 Aug; 22(4):1846-8. PubMed ID: 2143863 [No Abstract] [Full Text] [Related]
56. CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming growth factor-beta 2-related immunosuppressive factors. Clark DA; Vince G; Flanders KC; Hirte H; Starkey P Hum Reprod; 1994 Dec; 9(12):2270-7. PubMed ID: 7536211 [TBL] [Abstract][Full Text] [Related]
57. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells. Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983 [TBL] [Abstract][Full Text] [Related]
58. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Ghoneum M; Jewett A Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563 [TBL] [Abstract][Full Text] [Related]
59. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. Martinez OM; Gibbons RS; Garovoy MR; Aronson FR J Immunol; 1990 Mar; 144(6):2211-5. PubMed ID: 1968925 [TBL] [Abstract][Full Text] [Related]
60. Propagation of large numbers of T cells with natural killer cell markers. Schmidt-Wolf IG; Lefterova P; Johnston V; Huhn D; Blume KG; Negrin RS Br J Haematol; 1994 Jul; 87(3):453-8. PubMed ID: 7527643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]